ClinicalTrials.Veeva

Menu

PET-CT to Assess Brain Damage in Cardiac Arrest Patients

C

Capital Medical University

Status

Not yet enrolling

Conditions

Brain Injuries
Cardiac Arrest

Treatments

Other: No interventions

Study type

Observational

Funder types

Other

Identifiers

NCT06660238
2024-9-26-836

Details and patient eligibility

About

This was a single-center, observational study. Patients with successful cardiopulmonary resuscitation (CPR) will be transferred to the emergency intensive care unit for further standardized management. After successful return of spontaneous circulation (ROSC) for 72 hours and hemodynamic stability for 24 hours, the patients underwent positron emission computed tomography (PET-CT) examination after resuscitation. The supervising physician accompanied the patient and used monitors to monitor vital signs during the examination. Patients who were on ventilators were mechanically ventilated with a magnetic ventilator (HAMILTON-MRI, United States). In addition to conventional cerebral oxygen metabolism, cerebral blood flow, oxygen extraction fraction, cerebral blood volume and other indicators were added in this experiment. These indicators can evaluate the patient's cerebral metabolism, cerebral blood flow and cerebral blood oxygen damage degree. The neurological outcome was followed up 6 months after onset according to the cerebral performance category(CPC).

Enrollment

30 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • age ≥18 years.
  • sustained hemodynamic stability for ≥24h.
  • the patients were unconscious and not able to obey verbal commands. • Advanced life support and target temperature management within 6 hours of return of spontaneous circulation (ROSC).

Exclusion criteria

  • Patients with hemodynamic instability.
  • Patients who could not complete cranial PET-CT examination for special reasons. • Patients during pregnancy.
  • Patients who combined traumatic brain injury, stroke, cerebral hemorrhage and other diseases.
  • Patients whose family members did not agree to be enrolled.

Trial contacts and locations

1

Loading...

Central trial contact

Ziren Tang

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems